P
Parveen
About Parveen
Data last updated:
Parveen is a Director at Macin Remedies India Limited (since 2021) and Director at Dr Mendeleev Research And Formulation Limited (since 2018). The companies operate in Pharma. The largest current company by reported revenue is Macin Remedies India Limited at ₹23.02 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Mar 2021 | 2012 | ₹23.02 Cr (FY 2025) | Active | |
| Director | 26 Dec 2018 | 2018 | Active |
Board colleagues of Parveen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Avtar Singh Saggu | 02376991 | Macin Remedies India Limited , Dr Mendeleev Research And Formulation Limited | Director |
| Baljeet Kaur | 05270294 | Macin Remedies India Limited , Dr Mendeleev Research And Formulation Limited | Director |
| Pramod Kumar Singh | 10043927 | Macin Remedies India Limited | Director |
| Muneet Singh Saggu | 08314146 | Dr Mendeleev Research And Formulation Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Parveen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parveen
Parveen currently holds 2 directorships: Macin Remedies India Limited (Director, since 01 Mar 2021, revenue ₹23.02 Cr (FY 2025)); Dr Mendeleev Research And Formulation Limited (Director, since 26 Dec 2018).
Parveen was first appointed on 26 Dec 2018 as Director at Dr Mendeleev Research And Formulation Limited. The most recent appointment on record is 01 Mar 2021 at Macin Remedies India Limited.
The current boards of Parveen's companies include Avtar Singh Saggu (Macin Remedies India Limited), Baljeet Kaur (Macin Remedies India Limited), Pramod Kumar Singh (Macin Remedies India Limited), Muneet Singh Saggu (Dr Mendeleev Research And Formulation Limited).